Healthcare Triangle, Inc. HCTI
0.78
0.05
6.85%
as of 25 Sep
- Market cap
- $10.5M
- P/E
- 0.0×
Follow HCTI
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
0.17 | 0.50 | 0.39 | 0.12 | 225,623.57 | 462,544.22 | 462,544.22 | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
(0.34) | (7.27) | 21.36 | (2.53) | (2,460,650.34) | (39,459,741.43) | (39,459,741.43) | — |
P/B ratio |
0.94 | 0.00 | 0.00 | 0.46 | 493,197.59 | 5,712,467.18 | 5,712,467.18 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 10.68 | 1,813,523.97 | 21,857,027.89 | 21,857,027.89 | — |
EV/Sales |
0.46 | 0.80 | 0.47 | 0.15 | 225,623.58 | 462,544.24 | 462,544.24 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(0.38) | (8.71) | (7.18) | (2.58) | (1,118,917.83) | (5,924,024.14) | (5,924,024.14) | — |
EV/FCF |
(0.35) | (3.97) | (2.84) | (0.75) | (1,103,770.48) | (5,812,716.34) | (5,812,716.34) | — |
Quick Ratio |
0.76 | 0.16 | 0.59 | 1.13 | 1.83 | 1.15 | 0.83 | — |
Current Ratio |
1.03 | 0.21 | 0.69 | 1.26 | 1.89 | 1.18 | 0.85 | — |
Net Debt/EBITDA |
(0.35) | (0.91) | (0.43) | (0.15) | (0.11) | (0.33) | (0.40) | — |
Debt/Assets |
47.22% | 135.14% | 56.65% | 11.62% | 8.97% | 6.79% | 0.00% | 0.00% |
Debt/Equity |
1.08 | (0.52) | (2.79) | 0.19 | 0.14 | 0.17 | 0.00 | — |
Asset Turnover |
1.12 | 2.65 | 2.40 | 2.02 | 1.97 | 3.24 | 6.96 | — |
Operating CF/Net income |
1.74 | 0.18 | 0.25 | 0.27 | 1.20 | (0.31) | 3.39 | — |
Capex/Depreciation |
(1.62) | 0.00 | (0.01) | (0.98) | (2.20) | (0.59) | (4.70) | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| 188.76% | 85.64% | (157.97%) | (67.38%) | (58.14%) | 74.67% | 37.19% | — | |
| (76.74%) | (135.37%) | (62.89%) | (42.36%) | (33.31%) | 24.31% | 28.41% | — | |
ROIC |
(46.86%) | 0.00% | (381.70%) | (48.37%) | (20.20%) | 19.98% | 104.31% | — |
Return on Tangible Assets |
(2,603.30%) | 106.38% | 353.81% | (571.68%) | (105.72%) | 186.14% | (135.47%) | — |
Average Days of Receivables |
54.39 | 34.64 | 39.52 | 44.48 | 100.09 | 74.50 | 52.97 | — |
Research and Development Expense of Revenue |
3.86% | 3.67% | 2.41% | 12.98% | 14.91% | 5.56% | 3.53% | — |
Selling, General and Administrative Expense of Revenue |
75.02% | 52.61% | 31.31% | 26.99% | 26.09% | 15.52% | 8.32% | — |
Intangible Assets out of Total Assets |
0.25 | 0.00 | 0.13 | 0.57 | 0.48 | 0.24 | 0.35 | 0.00 |
Share Based Compensation of Revenue |
3.25% | 0.74% | 0.50% | 0.56% | 0.15% | 0.00% | 0.00% | — |
Graham Net Nets |
0.15 | (0.95) | (0.20) | (0.11) | 0.00 | 0.00 | 0.00 | — |
Graham Number |
0.00 | 110,236.78 | 57,279.44 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(309.62%) | (116.87%) | (73.73%) | (112.08%) | 0.00% | 0.00% | 0.00% | — |
Free Cash Flow Yield |
(767.01%) | (40.26%) | (42.53%) | (158.82%) | 0.00% | 0.00% | 0.00% | — |
Revenue per Share |
224.41 | 29,240.00 | 110,676.67 | 229,430.00 | 1.20 | 1.12 | 8.17 | — |
Operating CF per Share |
(266.93) | (2,702.50) | (7,170.00) | (13,000.00) | (0.24) | (0.03) | 1.13 | — |
Capex per Share |
(24.30) | 0.00 | (40.00) | (16,595.00) | (0.11) | (0.02) | (1.04) | — |
Free Cash Flow per Share |
(291.23) | (2,702.50) | (7,210.00) | (29,595.00) | (0.35) | (0.04) | 0.09 | — |
Cash per Share |
123.18 | 50.00 | 4,113.33 | 6,705.00 | 0.06 | 0.05 | 0.28 | — |
Shareholders Equity per Share |
160.65 | (12,785.00) | (4,636.67) | 61,940.00 | 0.55 | 0.16 | 0.56 | — |
Interest Debt per Share |
0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
160.65 | (12,785.00) | (4,636.67) | 61,940.00 | 0.55 | 0.16 | 0.56 | — |
Free Cash Flow |
(18.03) | (1.08) | (2.16) | (5.92) | (10.24) | (1.21) | 0.32 | — |
Working Capital |
0.36 | (5.62) | (2.50) | 1.60 | 5.55 | 1.25 | (0.91) | — |
Capital Expenditures |
(1.50) | — | (0.01) | (3.32) | (3.13) | (0.48) | (3.65) | — |
Net Current Asset Value |
0.36 | (5.62) | (2.60) | (0.63) | 3.33 | 1.25 | (0.99) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.11 | 0.00 | 0.00 | 0.07 | 0.09 | 0.02 | 0.13 | — |
Net Profit Margin |
(68.22%) | (51.03%) | (26.16%) | (20.94%) | (16.87%) | 7.51% | 4.08% | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
185.60 | 155.67 | 35.59 | 42.18 | 19.22 | 50.84 | 18.66 | — |
Cash ROIC |
(58.39%) | 44.72% | (58.88%) | (16.60%) | (35.73%) | (11.57%) | 133.11% | — |
Accounts Receivable Turnover |
8.74 | 4.97 | 7.23 | 6.01 | 4.39 | 5.93 | 5.44 | — |
Accounts Payable Turnover |
7.31 | 3.92 | 15.39 | 20.63 | 7.95 | 4.82 | 4.84 | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
22.63 | 105.24 | 26.98 | 15.63 | 27.62 | 69.78 | 81.33 | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
1.59 | 2.35 | 4.59 | 7.63 | 8.03 | 5.28 | 5.28 | — |
Average Payables |
1.64 | 2.25 | 1.72 | 1.68 | 3.11 | 4.72 | 4.72 | — |
Average Assets |
12.35 | 4.41 | 13.81 | 22.69 | 17.86 | 9.68 | 4.13 | — |
Average Common Equity |
(5.02) | (6.97) | 5.50 | 14.26 | 10.23 | 3.15 | 3.15 | — |
Columns are period end dates